Literature DB >> 8569297

Tumor markers. An update.

R J Pamies1, D R Crawford.   

Abstract

Cancer remains the second leading cause of death in developed countries, and the incidence of certain tumors is increasing despite emphasis on prevention and screening. Tumor markers are biologic or biochemical substances that are produced by tumor cells and then secreted into the circulation in detectable amounts. This article covers some of the more common tumor markers currently being utilized for diagnostic and prognostic purposes.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8569297     DOI： 10.1016/s0025-7125(05)70435-1

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  10 in total

1.  The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women.

Authors:  Jalila Rahoui; Yassir Sbitti; Nadia Touil; Abdelilah Laraqui; Azeddine Ibrahimi; Brahim Rhrab; Abderrahman Al Bouzidi; Driss Moussaoui Rahali; Mohamed Dehayni; Mohamed Ichou; Fatima Zaoui; Saad Mrani
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

2.  Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer.

Authors:  E Polat; U Duman; M Duman; A E Atici; E Reyhan; T Dalgic; E B Bostanci; S Yol
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

3.  Expression of CA125 and cisplatin susceptibility of pleural effusion-derived human lung cancer cells from a Thai patient.

Authors:  Pithi Chanvorachote; Sudjit Luanpitpong; Preedakorn Chunhacha; Worrawat Promden; Virote Sriuranpong
Journal:  Oncol Lett       Date:  2012-05-10       Impact factor: 2.967

4.  Significance of tumor markers in lung cancer.

Authors:  P P Mumbarkar; A S Raste; M S Ghadge
Journal:  Indian J Clin Biochem       Date:  2006-03

5.  Serum human epididymis protein 4 levels in colorectal cancer patients.

Authors:  Yasemi N Kemal; Guzi N Demirag; Abdulkeri M Bedir; Leman Tomak; Murat Derebey; Di Lek Erdem; Ufuk Gör; Idris Yücel
Journal:  Mol Clin Oncol       Date:  2017-07-19

6.  A reliable biomarker derived from plasmalogens to evaluate malignancy and metastatic capacity of human cancers.

Authors:  Rosina E Smith; Pablo Lespi; María Di Luca; Claudia Bustos; Fernando A Marra; María J T de Alaniz; Carlos A Marra
Journal:  Lipids       Date:  2007-11-29       Impact factor: 1.880

7.  Lung tumour markers in oncology practice: a study of TPA and CA125.

Authors:  G Buccheri; D Ferrigno
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

8.  Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer.

Authors:  Sushil Kumar Sharma; Sanjay Bhat; Vikas Chandel; Mayank Sharma; Pulkit Sharma; Sakul Gupta; Sashank Sharma; Aijaz Ahmed Bhat
Journal:  J Carcinog       Date:  2015-11-27

9.  Clinical evaluation and cost-effectiveness analysis of serum tumor markers in lung cancer.

Authors:  Rong Wang; Guoqing Wang; Nan Zhang; Xue Li; Yunde Liu
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

10.  Effect of Naringenin on metabolic markers, lipid profile and expression of GFAP in C6 glioma cells implanted rat's brain.

Authors:  S Devan; V A Janardhanam
Journal:  Ann Neurosci       Date:  2011-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.